United States · FDA National Drug Code directory
Tarpeyo
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 81749-004_48e9b876-94c8-7c9f-e063-6294a90adcef
- Product NDC
- 81749-004
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- budesonide
- Labeler
- Calliditas Therapeutics AB
- Marketing category
- NDA
- Marketing start / end (source format)
- 20211215
- Source listing expiry
- 20271231
Source-listed ingredients
- BUDESONIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 CAPSULE, DELAYED RELEASE in 1 BOTTLE (81749-004-01) · 81749-004-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →